Serotonergic targets for the treatment of l-DOPA-induced dyskinesia
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Neural Transmission"
DOI: 10.1007/s00702-017-1837-1
Abstract: Dopamine (DA) replacement therapy with l-3,4-dihydroxyphenylalanine (l-DOPA) continues to be the gold-standard treatment for Parkinson’s disease (PD). Despite clear symptomatic benefit, long-term l-DOPA use often results in the development of l-DOPA-induced dyskinesia (LID), significantly reducing… read more here.
Keywords: targets treatment; treatment; serotonergic targets; dopa ... See more keywords